132 related articles for article (PubMed ID: 15013519)
21. Targeting RAS signalling pathways in cancer therapy.
Downward J
Nat Rev Cancer; 2003 Jan; 3(1):11-22. PubMed ID: 12509763
[TBL] [Abstract][Full Text] [Related]
22. The impact of the regulatory design on the response of epidermal growth factor receptor-mediated signal transduction towards oncogenic mutations.
Wolf J; Dronov S; Tobin F; Goryanin I
FEBS J; 2007 Nov; 274(21):5505-17. PubMed ID: 17916191
[TBL] [Abstract][Full Text] [Related]
23. Targeting new anticancer drugs within signalling pathways regulated by the Ras GTPase superfamily (Review).
Ramírez De Molina A; Rodríguez-González A; Lacal JC
Int J Oncol; 2001 Jul; 19(1):5-17. PubMed ID: 11408916
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism.
Rodríguez-González A; Ramírez de Molina A; Bañez-Coronel M; Megias D; Lacal JC
Int J Oncol; 2005 Apr; 26(4):999-1008. PubMed ID: 15753995
[TBL] [Abstract][Full Text] [Related]
25. Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action.
Rodríguez-González A; Ramirez de Molina A; Fernández F; Lacal JC
Oncogene; 2004 Oct; 23(50):8247-59. PubMed ID: 15378008
[TBL] [Abstract][Full Text] [Related]
26. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling.
Lee SG; Su ZZ; Emdad L; Sarkar D; Franke TF; Fisher PB
Oncogene; 2008 Feb; 27(8):1114-21. PubMed ID: 17704808
[TBL] [Abstract][Full Text] [Related]
27. Interactions of Ras proteins with the plasma membrane and their roles in signaling.
Eisenberg S; Henis YI
Cell Signal; 2008 Jan; 20(1):31-9. PubMed ID: 17888630
[TBL] [Abstract][Full Text] [Related]
28. Ras initiates phosphatidyl-inositol-3-kinase (PI3K)/PKB mediated signalling pathways in untransformed human peripheral blood T lymphocytes.
Samstag Y; Nebl G
Adv Enzyme Regul; 2005; 45():52-62. PubMed ID: 16083947
[TBL] [Abstract][Full Text] [Related]
29. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
30. Key cancer cell signal transduction pathways as therapeutic targets.
Bianco R; Melisi D; Ciardiello F; Tortora G
Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
[TBL] [Abstract][Full Text] [Related]
31. Harnessing RNAi for analyses of Ras signaling and transformation.
Whitehurst AW; White MA
Methods Enzymol; 2006; 407():259-68. PubMed ID: 16757330
[TBL] [Abstract][Full Text] [Related]
32. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.
Friday BB; Adjei AA
Clin Cancer Res; 2008 Jan; 14(2):342-6. PubMed ID: 18223206
[TBL] [Abstract][Full Text] [Related]
33. Ras up-regulation of cyclooxygenase-2.
Backlund MG; Mann JR; Wang D; Dubois RN
Methods Enzymol; 2006; 407():401-10. PubMed ID: 16757341
[TBL] [Abstract][Full Text] [Related]
34. Role of tyrosine kinase inhibitors in cancer therapy.
Arora A; Scholar EM
J Pharmacol Exp Ther; 2005 Dec; 315(3):971-9. PubMed ID: 16002463
[TBL] [Abstract][Full Text] [Related]
35. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
Shmulevitz M; Marcato P; Lee PW
Oncogene; 2005 Nov; 24(52):7720-8. PubMed ID: 16299532
[TBL] [Abstract][Full Text] [Related]
36. Rho GTPases: potential candidates for anticancer therapy.
Aznar S; Fernández-Valerón P; Espina C; Lacal JC
Cancer Lett; 2004 Apr; 206(2):181-91. PubMed ID: 15013523
[TBL] [Abstract][Full Text] [Related]
37. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
38. Regulation of neuronal K(Ca) channels by beta-neuregulin-1 does not require activation of Ras-MEK-extracellular signal-regulated kinase signaling cascades.
Chae KS; Dryer SE
Neuroscience; 2005; 135(4):1013-6. PubMed ID: 16165293
[TBL] [Abstract][Full Text] [Related]
39. Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway.
Ram R; Uziel O; Eldan O; Fenig E; Beery E; Lichtenberg S; Nordenberg Y; Lahav M
Clin Cancer Res; 2009 Feb; 15(3):914-23. PubMed ID: 19188162
[TBL] [Abstract][Full Text] [Related]
40. Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis.
Ramírez de Molina A; Gallego-Ortega D; Sarmentero J; Bañez-Coronel M; Martín-Cantalejo Y; Lacal JC
Cancer Res; 2005 Jul; 65(13):5647-53. PubMed ID: 15994937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
